Literature DB >> 8494708

Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation.

N Aass1, B Grünfeld, O Kaalhus, S D Fosså.   

Abstract

Aspects of sexuality were assessed by questionnaires in 76 testicular cancer patients after orchiectomy before further treatment and, respectively, 6, 12 and 36 months after therapy. Before treatment 11% of the patients reported dissatisfaction with sexual life. About 20% of the patients sometimes experienced reduced libido and erectile difficulties. Six months after therapy significantly more patients (27%) recorded an unsatisfactory sexual life as compared to the pretreatment situation. At the 36 months' evaluation 22 of 76 evaluable patients (18%) still stated that their sexual life was inferior to the pretreatment experience. Libido and erectile function decreased transiently during the first year after treatment in most patients. Twelve patients reported permanent 'dry ejaculation' after bilateral retroperitoneal lymph node dissection. Other sexual disturbances could not be related to specified treatment modalities. Increased age at the time of diagnosis and psychological distress tended to correlate with the incidence of sexual problems. For about 60% of the patients the discussion of expected and experienced sexual life problems was an important issue to be discussed before their treatment for testicular cancer and during follow-up. The high frequency of any kind of long-lasting sexual problems (30%), though often of minor degree, warrants an adequate counselling of these patients before and after treatment.

Entities:  

Mesh:

Year:  1993        PMID: 8494708      PMCID: PMC1968446          DOI: 10.1038/bjc.1993.204

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Psychosocial well-being in testicular cancer patients.

Authors:  S Kaasa; N Aass; A Mastekaasa; E Lund; S D Fosså
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

2.  Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy.

Authors:  P Hoskin; S Dilly; D Easton; A Horwich; W Hendry; M J Peckham
Journal:  J Clin Oncol       Date:  1986-07       Impact factor: 44.544

3.  Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.

Authors:  G Stoter; A Koopman; C P Vendrik; A Struyvenberg; D T Sleyfer; P H Willemse; H Schraffordt Koops; A T van Oosterom; W W ten Bokkel Huinink; H M Pinedo
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

4.  Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men.

Authors:  P P Rieker; E M Fitzgerald; L A Kalish; J P Richie; G S Lederman; S D Edbril; M B Garnick
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

5.  Curative testis cancer therapy: psychosocial sequelae.

Authors:  P P Rieker; S D Edbril; M B Garnick
Journal:  J Clin Oncol       Date:  1985-08       Impact factor: 44.544

6.  Sexual and marital relationships after radiotherapy for seminoma.

Authors:  L R Schover; M Gonzales; A C von Eschenbach
Journal:  Urology       Date:  1986-02       Impact factor: 2.649

7.  Testicular cancer: the psychosocial problems of patients and their relatives.

Authors:  C Moynihan
Journal:  Cancer Surv       Date:  1987

8.  Sexual and marital relationships after treatment for nonseminomatous testicular cancer.

Authors:  L R Schover; A C von Eschenbach
Journal:  Urology       Date:  1985-03       Impact factor: 2.649

9.  Sexual function after surgery and combination chemotherapy in men with disseminated nonseminomatous testicular cancer.

Authors:  J M Nijman; H Schraffordt Koops; J Oldhoff; J Kremer; D T Sleijfer
Journal:  J Surg Oncol       Date:  1988-07       Impact factor: 3.454

10.  Renal function related to different treatment modalities for malignant germ cell tumours.

Authors:  N Aass; S D Fosså; M Aas; M W Lindegaard
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

View more
  2 in total

1.  Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.

Authors:  J Baniel; B J Roth; R S Foster; J P Donohue
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

2.  Sexuality and cancer in adolescents and young adults - a comparison between reproductive cancer patients and patients with non-reproductive cancer.

Authors:  Julian Mütsch; Michael Friedrich; Katja Leuteritz; Annekathrin Sender; Kristina Geue; Anja Hilbert; Yve Stöbel-Richter
Journal:  BMC Cancer       Date:  2019-08-22       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.